News Conference News TCT 2025 PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States Caitlin E. Cox October 27, 2025
News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf L.A. McKeown September 18, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Opinion Off Script TCT 2019 Off Script: The New Gatekeepers of Procedural Education Kwan S. Lee September 28, 2019